Abstract
Objective: To study the role of placental pathology in predicting the recurrence of delivery of small for gestational age (SGA) neonates. Methods: The medical records and placental pathological reports of normotensive women who gave birth at 24 to 42 weeks to neonates with birth weight (BW) <10th percentile were reviewed. Patients were divided according to their subsequent pregnancy into those who developed or did not develop recurrent SGA (BW < 10th percentile). The clinical and pathological characteristics of the index pregnancies were compared between the groups. A prediction model was generated for SGA recurrence. Results: The recurrent SGA group (n = 67) was characterized by a higher rate of placental weight <10th percentile (P = .01), and higher neonatal to placental weight ratio (P = .003), as compared to the nonrecurrent SGA group (n = 99). On multivariate logistic regression analysis, placental maternal and fetal vascular malperfusion lesions and higher neonatal to placental weight ratio were all independently associated with recurrent SGA. Birth weight <3rd percentile was the only clinical variable associated with recurrent SGA. A prediction model for recurrent SGA included the following independent risk factors: BW <3rd percentile, villous lesions of maternal vascular malperfusion, and neonatal to placental weight ratio. Conclusion: The presence of placental vascular malperfusion lesions and increased neonatal to placental weight ratio at index pregnancy are associated with recurrent SGA in subsequent pregnancy.
Similar content being viewed by others
References
Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49(2):270–283.
Barker DJ. Fetal origins of coronary heart disease. Br Med J. 1995;311(6998):171–174. doi:10.1136/bmj.311.6998.171
Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol. 2011;37(5):501–514. doi:10.1002/uog.9008
Barker DJ. Early growth and cardiovascular disease. Arch Dis Child. 1999;80(4):305–307.
Bakketeig LS, Bjerkedal T, Hoffman HJ. Small-for-gestational age births in successive pregnancy outcomes: results from a longitudinal study of births in Norway. Early Hum Dev. 1986;14(3-4): 187–200.
Patterson RM, Gibbs CE, Wood RC. Birth weight percentile and perinatal outcome: recurrence of intrauterine growth retardation. Obstet Gynecol. 1986;68(4):464–468.
Voskamp BJ, Kazemier BM, Ravelli AC, Schaaf J, Mol BW, Pajkrt E. Recurrence of small-for-gestational-age pregnancy: analysis of first and subsequent singleton pregnancies in the Netherlands. Am J Obstet Gynecol. 2013;208(5):374.e1-6. doi:10. 1016/j.ajog.2013.01.045
Basso O, Olsen J, Christensen K. Low birthweight and prematurity in relation to paternal factors: a study of recurrence. Int J Epidemiol. 1999;28(4):695–700. doi:10.1093/ije/28.4.695
Bakewell JM, Stockbauer JW, Schramm WF. Factors associated with repetition of low birthweight: Missouri longitudinal study. Paediatr Perinat Epidemiol. 1997;11(Suppl 1):119–129. http://www.ncbi.nlm.nih.gov/pubmed/9018721.
Sclowitz IK, Santos IS, Domingues MR, Matijasevich A, Barros AJ. Prognostic factors for low birthweight repetition in successive pregnancies: a cohort study. BMC Pregnancy Childbirth. 2013; 13:20. doi:10.1186/1471-2393-13-20
Nardozza LM, Caetano AC, Zamarian AC, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017; 295(5):1061–1077. doi:10.1007/s00404-017-4341-9
Tyson RW, Staat BC. The intrauterine growth-restricted fetus and placenta evaluation. Semin Perinatol. 2008;32(3):166–171. doi: 10.1053/j.semperi.2008.02.005
Vedmedovska N, Rezeberga D, Teibe U, Melderis I, Donders GGG. Placental pathology in fetal growth restriction. Eur J Obstet Gynecol Reprod Biol. 2011;155(1):36–40. doi:10.1016/j.ejogrb. 2010.11.017
Figueras F, Gratacos E. An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol. 2017;38:48–58. doi:10.1016/j.bpobgyn.2016.10.006
Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol. 2008;61(12):1254–1260. doi:10.1136/jcp.2008.055236
Mayhew TM, Wijesekara J, Baker PN, Ong SS. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta. 2004;25(10):829–833. doi:10.1016/j.placenta.2004.04.011
Kadyrov M, Kingdom JCP, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset pree-clampsia/intrauterine growth restriction. Am J Obstet Gynecol. 2006;194(2):557–563. doi:10.1016/j.ajog.2005.07.035
Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2(2):72–83. doi:10.1016/j.preghy.2012. 01.001
Weiner E, Mizrachi Y, Grinstein E, et al. The role of placental histopathological lesions in predicting recurrence of preeclampsia. Prenat Diagn. 2016;36(10):953–960. doi:10.1002/pd.4918
Ananth CV, Peltier MR, Chavez MR, Kirby RS, Getahun D, Vintzileos AM. Recurrence of ischemic placental disease. Obstet Gynecol. 2007;110(1):128–133. doi:10.1097/01.AOG.000026 6983.77458.71
Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth-weight standards in the live-born population in Israel. Isr Med Assoc J. 2005;7(5):311–314.
Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation—a workshop report. Placenta. 2005;26(suppl A):S114–S117. doi:10.1016/j.placenta. 2005.02.009
Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698–713. doi: 10.5858/arpa.2015-0225-CC
Kovo M, Schreiber L, Ben-Haroush A, et al. The placental factor in early- and late-onset normotensive fetal growth restriction. Placenta. 2013;34(4):320–324. doi:10.1016/j.placenta.2012.11.010
Pinar H, Sung CJ, Oyer CE, Singer DB. Reference values for singleton and twin placental weights. Pediatr Pathol Lab Med. 1996;16(6):901–907.
Weiner E, Schreiber L, Grinstein E, et al. The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome. Placenta. 2016;47:99–104. doi:10.1016/j. placenta.2016.09.012
Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201. doi:10. 1016/j.ajog.2010.08.009
Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. Am J Obstet Gynecol. 2002;187(5):1416–1423. doi:10.1067/mob.2002. 127305
Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol. 1977; 84(9):656–663.
Veerbeek JHW, Nikkels PGJ, Torrance HL, et al. Placental pathology in early intrauterine growth restriction associated with maternal hypertension. Placenta. 2014;35(9):696–701. doi:10. 1016/j.placenta.2014.06.375
Parra-Saavedra M, Simeone S, Triunfo S, et al. Correlation between histological signs of placental underperfusion and perinatal morbidity in late-onset small-for-gestational-age fetuses. Ultrasound Obstet Gynecol. 2015;45(2):149–155. doi:10.1002/ uog.13415
Spinillo A, Gardella B, Bariselli S, Alfei A, Silini E, Dal Bello B. Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction. Prenat Diagn. 2012;32(13):1263–1272. doi:10.1002/pd.3988
Parra-Saavedra M, Crovetto F, Triunfo S, et al. Added value of umbilical vein flow as a predictor of perinatal outcome in term small-for-gestational-age fetuses. Ultrasound Obstet Gynecol. 2013;42(2):189–195. doi:10.1002/uog.12380
Parra-Saavedra M, Crovetto F, Triunfo S, et al. Association of Doppler parameters with placental signs of underperfusion in late-onset small-for-gestational-age pregnancies. Ultrasound Obstet Gynecol. 2014;44(3):330–337. doi:10.1002/uog.13358
Stevens DU, Al-Nasiry S, Bulten J, Spaanderman ME. Decidual vasculopathy in preeclampsia: lesion characteristics relate to disease severity and perinatal outcome. Placenta. 2013; 34(9):805–809. doi:10.1016/j.placenta.2013.05.008
Miranda J, Triunfo S, Rodriguez-Lopez M, et al. Performance of a third trimester combined screening model for the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2017; 50(3):353–360. doi:10.1002/uog.17317
Crovetto F, Triunfo S, Crispi F, et al. Differential performance of first-trimester screening in predicting small-for-gestationalage neonate or fetal growth restriction. Ultrasound Obstet Gynecol. 2017;49(3):349–356. doi:10.1002/uog.15919
Poon LC, Lesmes C, Gallo DM, Akolekar R, Nicolaides KH. Prediction of small-for-gestationalage neonates: screening by biophysical and biochemical markers at 19-24 weeks. Ultrasound Obstet Gynecol. 2015;46(4):437–445. doi:10.1002/uog.14904
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. Systematic review the role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110–120.e6. doi:10.1016/j.ajog.2016.09.076
Parrasaavedra M, Crovetto F, Triunfo S, et al. Placental findings in late-onset SGA births without Doppler signs of placental insufficiency. Placenta. 2013;34(12):1136–1141. doi:10.1016/j.placenta.2013.09.018
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levy, M., Mizrachi, Y., Leytes, S. et al. Can Placental Histopathology Lesions Predict Recurrence of Small for Gestational Age Neonates?. Reprod. Sci. 25, 1485–1491 (2018). https://doi.org/10.1177/1933719117749757
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719117749757